www.botox.com Open in urlscan Pro
3.167.88.44  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to Main content
 * Important Safety Information
 * Prescribing Information & Patient Information
    * Important Safety Information
    * Medication Guide
    * BOTOX® Product Information
    * Healthcare Professionals Site

 * Healthcare Professionals Site

LOG IN
 * 
 * Manage Profile
 * Change Password
 * Treatment Reminders
 * Dashboard
 * Log Out



 * Find a BOTOX® Specialist
 * BOTOX® Savings Program
 * Conditions
    * Chronic Migraine
   
    * Adult Spasticity
   
    * Blepharospasm
   
    * Cervical Dystonia
   
    * Pediatric Spasticity
   
    * Severe Underarm Sweating
   
    * Strabismus
   
    * Overactive Bladder
   
    * OAB due to neurologic condition
   
    * Pediatric OAB due to neurologic condition

 * Choose Your Condition
    * All Conditions
   
    * Adult Spasticity
   
    * Blepharospasm
   
    * Cervical Dystonia
   
    * Chronic Migraine
   
    * Adult Overactive Bladder
   
    * Adult Overactive Bladder Caused by a Neurologic Condition
   
    * Pediatric Overactive Bladder Caused by a Neurologic Condition
   
    * Pediatric Spasticity
   
    * Severe Underarm Sweating
   
    * Strabismus

 * Conditions





WHAT BRINGS YOU HERE TODAY?


FOR MEDICAL CONDITIONS

For treating over 12 different medical conditions including Chronic Migraine,
Spasticity, and Overactive Bladder.

LEARN MORE

Not a patient? Visit HCP Site


FOR AESTHETICS

For temporarily making moderate to severe frown lines, crow's feet, forehead
lines, and vertical bands connecting the jaw and neck (platysma bands) look
better in adults.

LEARN MORE

Not a patient? Visit HCP Site

BOTOX® Cosmetic Product Information


IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

 * Problems swallowing, speaking, or breathing, due to weakening of associated
   muscles, can be severe and result in loss of life. You are at the highest
   risk if these problems are preexisting before injection. Swallowing problems
   may last for several months.
 * Spread of toxin effects. The effect of botulinum toxin may affect areas away
   from the injection site and cause serious symptoms, including loss of
   strength and all-over muscle weakness; double vision; blurred vision;
   drooping eyelids; hoarseness or change or loss of voice; trouble saying words
   clearly; loss of bladder control; trouble breathing; and trouble swallowing.

There has not been a confirmed serious case of spread of toxin effect away from
the injection site when BOTOX has been used at the recommended dose to treat
chronic migraine, severe underarm sweating, blepharospasm, strabismus, or when
BOTOX Cosmetic has been used at the recommended dose to treat frown lines,
crow’s feet lines, forehead lines, or platysma bands.

INDICATIONS

BOTOX is a prescription medicine that is injected into muscles and used:

 * To treat overactive bladder symptoms such as a strong need to urinate with
   leaking or wetting accidents (urge urinary incontinence), a strong need to
   urinate right away (urgency), and urinating often (frequency) in adults 18
   years and older when another type of medicine (anticholinergic) does not work
   well enough or cannot be taken
 * To treat leakage of urine (incontinence) in adults 18 years and older with
   overactive bladder due to a neurologic disease when another type of medicine
   (anticholinergic) does not work well enough or cannot be taken
 * To treat overactive bladder due to a neurologic disease in children 5 years
   of age and older when another type of medicine (anticholinergic) does not
   work well enough or cannot be taken
 * To prevent headaches in adults with chronic migraine who have 15 or more days
   each month with headache lasting 4 or more hours each day in people 18 years
   and older
 * To treat increased muscle stiffness in people 2 years of age and older with
   spasticity
 * To treat the abnormal head position and neck pain that happens with cervical
   dystonia (CD) in people 16 years and older
 * To treat certain types of eye muscle problems (strabismus) or abnormal spasm
   of the eyelids (blepharospasm) in people 12 years of age and older

BOTOX is also injected into the skin to treat the symptoms of severe underarm
sweating (severe primary axillary hyperhidrosis) when medicines used on the skin
(topical) do not work well enough in people 18 years and older.

BOTOX Cosmetic is a prescription medicine that is injected into muscles and used
to temporarily improve the look of moderate to severe forehead lines, crow’s
feet lines, frown lines between the eyebrows in adults, and vertical bands
connecting the jaw and neck (platysma bands) in adults. 

It is not known whether BOTOX and BOTOX Cosmetic are safe and effective to
prevent headaches in patients with migraine who have 14 or fewer headache days
each month (episodic migraine).

BOTOX has not been shown to help people perform task-specific functions with
their upper limbs or increase movement in joints that are permanently fixed in
position by stiff muscles. 

It is not known whether BOTOX and BOTOX Cosmetic are safe and effective for
severe sweating anywhere other than your armpits.

It is not known if BOTOX Cosmetic is safe and effective for use more than 1 time
every 3 months. 

IMPORTANT SAFETY INFORMATION (continued)

BOTOX and BOTOX Cosmetic may cause loss of strength or general muscle weakness,
vision problems, or dizziness within hours to weeks of receiving BOTOX or BOTOX
Cosmetic. If this happens, do not drive a car, operate machinery, or do other
dangerous activities.

Do not receive BOTOX or BOTOX Cosmetic if you are allergic to any of its
ingredients (see Medication Guide for ingredients); had an allergic reaction to
any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), Xeomin® (incobotulinumtoxinA), Jeuveau®
(prabotulinumtoxinA-xvfs), Daxxify® (daxibotulinumtoxinA-lanm), or Letybo®
(letibotulinumtoxinA-wlbg) (this may not be a complete list of all botulinum
toxin products); have a skin infection at the planned injection site.

Do not receive BOTOX for the treatment of urinary incontinence if you have a
urinary tract infection (UTI) or cannot empty your bladder on your own and are
not routinely catheterizing. Due to the risk of urinary retention (difficulty
fully emptying the bladder), only patients who are willing and able to initiate
catheterization posttreatment, if required, should be considered for treatment.

Patients treated for overactive bladder: In clinical trials, 36 of the 552
patients had to self-catheterize for urinary retention following treatment with
BOTOX compared to 2 of the 542 treated with placebo. The median duration of
postinjection catheterization for these patients treated with BOTOX 100 Units (n
= 36) was 63 days (minimum 1 day to maximum 214 days), as compared to a median
duration of 11 days 0 (minimum 3 days to maximum 18 days) for patients receiving
placebo (n = 2). Patients with diabetes mellitus treated with BOTOX were more
likely to develop urinary retention than nondiabetics.

Adult patients treated for overactive bladder due to neurologic disease: In
clinical trials, 30.6% of adult patients (33/108) who were not using clean
intermittent catheterization (CIC) prior to injection required catheterization
for urinary retention following treatment with BOTOX 200 Units, as compared to
6.7% of patients (7/104) treated with placebo. The median duration of
postinjection catheterization for these patients treated with BOTOX 200 Units (n
= 33) was 289 days (minimum 1 day to maximum 530 days), as compared to a median
duration of 358 days (minimum 2 days to maximum 379 days) for patients receiving
placebo (n = 7).

Among adult patients not using CIC at baseline, those with MS were more likely
to require CIC postinjection than those with SCI.

The dose of BOTOX and BOTOX Cosmetic is not the same as, or comparable to, any
other botulinum toxin product.

Serious and/or immediate allergic reactions have been reported, including
itching; rash; red, itchy welts; wheezing; asthma symptoms; dizziness; or
feeling faint. Get medical help right away if you experience symptoms; further
injection of BOTOX or BOTOX Cosmetic should be discontinued.

Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou
Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects, including difficulty swallowing and
difficulty breathing from typical doses of BOTOX or BOTOX Cosmetic.

Tell your doctor if you have any breathing-related problems. Your doctor may
monitor you for breathing problems during treatment with BOTOX for spasticity or
for detrusor overactivity associated with a neurologic condition. The risk of
developing lung disease in patients with reduced lung function is increased in
patients receiving BOTOX.

Cornea problems have been reported. Cornea (surface of the eye) problems have
been reported in some people receiving BOTOX for their blepharospasm, especially
in people with certain nerve disorders. BOTOX may cause the eyelids to blink
less, which could lead to the surface of the eye being exposed to air more than
is usual. Tell your doctor if you experience any problems with your eyes while
receiving BOTOX. Your doctor may treat your eyes with drops, ointments, contact
lenses, or with an eye patch.

Bleeding behind the eye has been reported. Bleeding behind the eyeball has been
reported in some people receiving BOTOX for their strabismus. Tell your doctor
if you notice any new visual problems while receiving BOTOX.

Bronchitis and upper respiratory tract infections (common colds) have been
reported. Bronchitis was reported more frequently in adults receiving BOTOX for
upper limb spasticity. Upper respiratory infections were also reported more
frequently in adults with prior breathing-related problems with spasticity. In
pediatric patients treated with BOTOX for upper limb spasticity, upper
respiratory tract infections were reported more frequently. In pediatric
patients treated with BOTOX for lower limb spasticity, upper respiratory tract
infections were not reported more frequently than placebo.

Autonomic dysreflexia in patients treated for overactive bladder due to a
neurologic disease. Autonomic dysreflexia associated with intradetrusor
injections of BOTOX could occur in patients treated for detrusor overactivity
associated with a neurologic condition and may require prompt medical therapy.
In clinical trials, the incidence of autonomic dysreflexia was greater in adult
patients treated with BOTOX 200 Units compared with placebo (1.5% versus 0.4%,
respectively).

Tell your doctor about all your medical conditions, including if you have or
have had bleeding problems; have plans to have surgery; had surgery on your
face; have weakness of forehead muscles, trouble raising your eyebrows, drooping
eyelids, and any other abnormal facial change; have symptoms of a UTI and are
being treated for urinary incontinence (symptoms of a UTI may include pain or
burning with urination, frequent urination, or fever); have problems emptying
your bladder on your own and are being treated for urinary incontinence; are
pregnant or plan to become pregnant (it is not known if BOTOX or BOTOX Cosmetic
can harm your unborn baby); are breastfeeding or plan to (it is not known if
BOTOX or BOTOX Cosmetic passes into breast milk).

Tell your doctor about all the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX or
BOTOX Cosmetic with certain other medicines may cause serious side effects. Do
not start any new medicines until you have told your doctor that you have
received BOTOX or BOTOX Cosmetic in the past.

Tell your doctor if you have received any other botulinum toxin product in the
last 4 months; have received injections of botulinum toxin such as Myobloc®,
Dysport®, Xeomin®, Jeuveau®, Daxxify®, or Letybo® in the past (this may not be a
complete list of all botulinum toxin products; tell your doctor exactly which
product you received); have recently received an antibiotic by injection; take
muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take
aspirin-like products or blood thinners.

Other side effects of BOTOX and BOTOX Cosmetic include dry mouth; discomfort or
pain at the injection site; tiredness; headache; neck pain; eye problems such as
double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of
your eyelids, and dry eyes; drooping eyebrows; and upper respiratory tract
infection. In adults being treated for urinary incontinence, other side effects
include UTI and painful urination. In children being treated for urinary
incontinence, other side effects include UTI; bacteria, white blood cells, and
blood in the urine. In patients being treated for urinary incontinence, another
side effect includes the inability to empty your bladder on your own. If you
have difficulty fully emptying your bladder on your own after receiving BOTOX,
you may need to use disposable self-catheters to empty your bladder up to a few
times each day until your bladder is able to start emptying again.

For more information, refer to the Medication Guide or talk with your doctor.

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see BOTOX® full Product Information, including Boxed Warning and
Medication Guide, or visit https://www.rxabbvie.com/pdf/botox_pi.pdf.

Please see BOTOX® Cosmetic full Product Information, including Boxed Warning and
Medication Guide, or visit https://www.rxabbvie.com/pdf/botox-cosmetic_pi.pdf.

If you are having difficulty paying for your medicine, AbbVie may be able to
help. Visit AbbVie.com/PatientAccessSupport to learn more.

US-BTX-240442

Program Terms, Conditions, and Eligibility Criteria: 1. Offer good only with a
valid prescription for BOTOX® (onabotulinumtoxinA). 2. Based on insurance
coverage, reimbursement may be up to $1300 for the first treatment in a year and
$1000 for each subsequent treatment with a maximum savings limit of $4000 per
year; patient out-of-pocket expense may vary. 3. Offer not valid for (a)
patients enrolled in Medicare, Medicaid, TRICARE or any other
government-reimbursed healthcare program (including any state pharmaceutical
assistance programs), or private indemnity or HMO insurance plans that reimburse
for the entire cost of prescription drugs; (b) patients who are
Medicare-eligible and enrolled in an employer-sponsored health plan or
prescription drug benefit program for retirees; (c) cash-paying patients. 4.
Offer valid for up to 5 treatments over a 12-month period. 5. Offer valid only
for BOTOX® and BOTOX® treatment-related costs not covered by insurance. For
residents of Massachusetts and Rhode Island, offer applies only to the cost of
BOTOX® and not to any related medical service(s). 6. Claims must be submitted
within 180 days of treatment date and must include a copy of (a) an Explanation
of Benefits (EOB) for the BOTOX® treatment, (b) a Specialty Pharmacy (SP)
receipt for BOTOX®, or (c) other writing showing payment of out-of-pocket BOTOX®
and treatment-related out-of-pocket costs. 7. A BOTOX® Savings Program check
will be issued to the patient upon approval of a claim. 8. Abbvie reserves the
right to rescind, revoke, or amend this offer without notice. 9. Offer good only
in the USA, including Puerto Rico, at participating retail locations. 10. Void
where prohibited by law, taxed, or restricted. 11. Offer does not constitute
health insurance. 12. By participating in the BOTOX® Savings Program, you
acknowledge and agree to the terms and conditions of this program. 13. Subject
to all other terms and conditions, the maximum annual benefit that may be
available solely for the patient's benefit under the copay assistance program is
$4000 per calendar year. The actual application and use of the benefit available
under the copay assistance program may vary on a monthly, quarterly, and/or
annual basis depending on each individual patient's plan of insurance and other
prescription drug costs. 14. To learn about AbbVie’s privacy practices and your
privacy choices, visit https://abbv.ie/corpprivacy

For questions about the program, please call 1-800-44-BOTOX (1-800-442-6869).

ABBVIE INFORMATION

 * Privacy Notice
 * Consumer Health Data Privacy Notice
 * Accessibility Statement
 * Terms of Use
 * Site Map
 * About AbbVie
 * Cookies Settings
 * Your Privacy Choices

CONDITIONS

 * Adult Spasticity
 * Blepharospasm
 * Cervical Dystonia
 * Chronic Migraine
 * Adult Overactive Bladder
 * Adult Overactive Bladder due to a Neurologic Condition
 * Pediatric Overactive Bladder
   due to a Neurologic Condition
 * Pediatric Spasticity
 * Severe Underarm Sweating
 * Strabismus

RESOURCES

 * BOTOX® Product Information
 * Medication Guide
 * BOTOX® Savings Program
 * Find a BOTOX® Specialist

HEALTHCARE PROFESSIONALS

 * BOTOX® One

--------------------------------------------------------------------------------

© 2024 AbbVie. All rights reserved.
BOTOX® and its design are registered trademarks of Allergan, Inc., an AbbVie
company.
All other trademarks are the property of their respective owners.

US-BTX-230479







LEAVING ABBVIE WEBSITE

You are leaving the BOTOX.com site and connecting to a site that is not under
the control of AbbVie. AbbVie is not responsible for the contents of any such
site or any further links from such site. AbbVie is providing these links to you
only as a convenience and the inclusion of any link does not imply the
endorsement of the linked site by AbbVie. You should also be aware that the
linked site may be governed by its own set of terms and conditions and privacy
policy for which AbbVie has no responsibility.

Conversely, the presence of this link does not imply the linked site's
endorsement of BOTOX.com or AbbVie.

DO YOU WISH TO LEAVE THIS SITE?

Yes
No



IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

IMPORTANT SAFETY INFORMATION

BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic may cause serious side effects
that can be life threatening. Get medical help right away if you have any of
these problems any time (hours to weeks) after injection of BOTOX or BOTOX
Cosmetic:

 * Problems swallowing, speaking, or breathing, due to weakening of associated
   muscles, can be severe and result in loss of life. You are at the highest
   risk if these problems are preexisting before injection. Swallowing problems
   may last for several months.
 * Spread of toxin effects. The effect of botulinum toxin may affect areas away
   from the injection site and cause serious symptoms, including loss of
   strength and all-over muscle weakness; double vision; blurred vision;
   drooping eyelids; hoarseness or change or loss of voice; trouble saying words
   clearly; loss of bladder control; trouble breathing; and trouble swallowing.

There has not been a confirmed serious case of spread of toxin effect away from
the injection site when BOTOX has been used at the recommended dose to treat
chronic migraine, severe underarm sweating, blepharospasm, strabismus, or when
BOTOX Cosmetic has been used at the recommended dose to treat frown lines,
crow’s feet lines, forehead lines, or platysma bands.

INDICATIONS

BOTOX is a prescription medicine that is injected into muscles and used:

 * To treat overactive bladder symptoms such as a strong need to urinate with
   leaking or wetting accidents (urge urinary incontinence), a strong need to
   urinate right away (urgency), and urinating often (frequency) in adults 18
   years and older when another type of medicine (anticholinergic) does not work
   well enough or cannot be taken
 * To treat leakage of urine (incontinence) in adults 18 years and older with
   overactive bladder due to a neurologic disease when another type of medicine
   (anticholinergic) does not work well enough or cannot be taken
 * To treat overactive bladder due to a neurologic disease in children 5 years
   of age and older when another type of medicine (anticholinergic) does not
   work well enough or cannot be taken
 * To prevent headaches in adults with chronic migraine who have 15 or more days
   each month with headache lasting 4 or more hours each day in people 18 years
   and older
 * To treat increased muscle stiffness in people 2 years of age and older with
   spasticity
 * To treat the abnormal head position and neck pain that happens with cervical
   dystonia (CD) in people 16 years and older
 * To treat certain types of eye muscle problems (strabismus) or abnormal spasm
   of the eyelids (blepharospasm) in people 12 years of age and older

BOTOX is also injected into the skin to treat the symptoms of severe underarm
sweating (severe primary axillary hyperhidrosis) when medicines used on the skin
(topical) do not work well enough in people 18 years and older.

BOTOX Cosmetic is a prescription medicine that is injected into muscles and used
to temporarily improve the look of moderate to severe forehead lines, crow’s
feet lines, frown lines between the eyebrows in adults, and vertical bands
connecting the jaw and neck (platysma bands) in adults. 

It is not known whether BOTOX and BOTOX Cosmetic are safe and effective to
prevent headaches in patients with migraine who have 14 or fewer headache days
each month (episodic migraine).

BOTOX has not been shown to help people perform task-specific functions with
their upper limbs or increase movement in joints that are permanently fixed in
position by stiff muscles. 

It is not known whether BOTOX and BOTOX Cosmetic are safe and effective for
severe sweating anywhere other than your armpits.

It is not known if BOTOX Cosmetic is safe and effective for use more than 1 time
every 3 months. 

IMPORTANT SAFETY INFORMATION (continued)

BOTOX and BOTOX Cosmetic may cause loss of strength or general muscle weakness,
vision problems, or dizziness within hours to weeks of receiving BOTOX or BOTOX
Cosmetic. If this happens, do not drive a car, operate machinery, or do other
dangerous activities.

Do not receive BOTOX or BOTOX Cosmetic if you are allergic to any of its
ingredients (see Medication Guide for ingredients); had an allergic reaction to
any other botulinum toxin product such as Myobloc® (rimabotulinumtoxinB),
Dysport® (abobotulinumtoxinA), Xeomin® (incobotulinumtoxinA), Jeuveau®
(prabotulinumtoxinA-xvfs), Daxxify® (daxibotulinumtoxinA-lanm), or Letybo®
(letibotulinumtoxinA-wlbg) (this may not be a complete list of all botulinum
toxin products); have a skin infection at the planned injection site.

Do not receive BOTOX for the treatment of urinary incontinence if you have a
urinary tract infection (UTI) or cannot empty your bladder on your own and are
not routinely catheterizing. Due to the risk of urinary retention (difficulty
fully emptying the bladder), only patients who are willing and able to initiate
catheterization posttreatment, if required, should be considered for treatment.

Patients treated for overactive bladder: In clinical trials, 36 of the 552
patients had to self-catheterize for urinary retention following treatment with
BOTOX compared to 2 of the 542 treated with placebo. The median duration of
postinjection catheterization for these patients treated with BOTOX 100 Units (n
= 36) was 63 days (minimum 1 day to maximum 214 days), as compared to a median
duration of 11 days 0 (minimum 3 days to maximum 18 days) for patients receiving
placebo (n = 2). Patients with diabetes mellitus treated with BOTOX were more
likely to develop urinary retention than nondiabetics.

Adult patients treated for overactive bladder due to neurologic disease: In
clinical trials, 30.6% of adult patients (33/108) who were not using clean
intermittent catheterization (CIC) prior to injection required catheterization
for urinary retention following treatment with BOTOX 200 Units, as compared to
6.7% of patients (7/104) treated with placebo. The median duration of
postinjection catheterization for these patients treated with BOTOX 200 Units (n
= 33) was 289 days (minimum 1 day to maximum 530 days), as compared to a median
duration of 358 days (minimum 2 days to maximum 379 days) for patients receiving
placebo (n = 7).

Among adult patients not using CIC at baseline, those with MS were more likely
to require CIC postinjection than those with SCI.

The dose of BOTOX and BOTOX Cosmetic is not the same as, or comparable to, any
other botulinum toxin product.

Serious and/or immediate allergic reactions have been reported, including
itching; rash; red, itchy welts; wheezing; asthma symptoms; dizziness; or
feeling faint. Get medical help right away if you experience symptoms; further
injection of BOTOX or BOTOX Cosmetic should be discontinued.

Tell your doctor about all your muscle or nerve conditions, such as ALS or Lou
Gehrig’s disease, myasthenia gravis, or Lambert-Eaton syndrome, as you may be at
increased risk of serious side effects, including difficulty swallowing and
difficulty breathing from typical doses of BOTOX or BOTOX Cosmetic.

Tell your doctor if you have any breathing-related problems. Your doctor may
monitor you for breathing problems during treatment with BOTOX for spasticity or
for detrusor overactivity associated with a neurologic condition. The risk of
developing lung disease in patients with reduced lung function is increased in
patients receiving BOTOX.

Cornea problems have been reported. Cornea (surface of the eye) problems have
been reported in some people receiving BOTOX for their blepharospasm, especially
in people with certain nerve disorders. BOTOX may cause the eyelids to blink
less, which could lead to the surface of the eye being exposed to air more than
is usual. Tell your doctor if you experience any problems with your eyes while
receiving BOTOX. Your doctor may treat your eyes with drops, ointments, contact
lenses, or with an eye patch.

Bleeding behind the eye has been reported. Bleeding behind the eyeball has been
reported in some people receiving BOTOX for their strabismus. Tell your doctor
if you notice any new visual problems while receiving BOTOX.

Bronchitis and upper respiratory tract infections (common colds) have been
reported. Bronchitis was reported more frequently in adults receiving BOTOX for
upper limb spasticity. Upper respiratory infections were also reported more
frequently in adults with prior breathing-related problems with spasticity. In
pediatric patients treated with BOTOX for upper limb spasticity, upper
respiratory tract infections were reported more frequently. In pediatric
patients treated with BOTOX for lower limb spasticity, upper respiratory tract
infections were not reported more frequently than placebo.

Autonomic dysreflexia in patients treated for overactive bladder due to a
neurologic disease. Autonomic dysreflexia associated with intradetrusor
injections of BOTOX could occur in patients treated for detrusor overactivity
associated with a neurologic condition and may require prompt medical therapy.
In clinical trials, the incidence of autonomic dysreflexia was greater in adult
patients treated with BOTOX 200 Units compared with placebo (1.5% versus 0.4%,
respectively).

Tell your doctor about all your medical conditions, including if you have or
have had bleeding problems; have plans to have surgery; had surgery on your
face; have weakness of forehead muscles, trouble raising your eyebrows, drooping
eyelids, and any other abnormal facial change; have symptoms of a UTI and are
being treated for urinary incontinence (symptoms of a UTI may include pain or
burning with urination, frequent urination, or fever); have problems emptying
your bladder on your own and are being treated for urinary incontinence; are
pregnant or plan to become pregnant (it is not known if BOTOX or BOTOX Cosmetic
can harm your unborn baby); are breastfeeding or plan to (it is not known if
BOTOX or BOTOX Cosmetic passes into breast milk).

Tell your doctor about all the medicines you take, including prescription and
over-the-counter medicines, vitamins, and herbal supplements. Using BOTOX or
BOTOX Cosmetic with certain other medicines may cause serious side effects. Do
not start any new medicines until you have told your doctor that you have
received BOTOX or BOTOX Cosmetic in the past.

Tell your doctor if you have received any other botulinum toxin product in the
last 4 months; have received injections of botulinum toxin such as Myobloc®,
Dysport®, Xeomin®, Jeuveau®, Daxxify®, or Letybo® in the past (this may not be a
complete list of all botulinum toxin products; tell your doctor exactly which
product you received); have recently received an antibiotic by injection; take
muscle relaxants; take an allergy or cold medicine; take a sleep medicine; take
aspirin-like products or blood thinners.

Other side effects of BOTOX and BOTOX Cosmetic include dry mouth; discomfort or
pain at the injection site; tiredness; headache; neck pain; eye problems such as
double vision, blurred vision, decreased eyesight, drooping eyelids, swelling of
your eyelids, and dry eyes; drooping eyebrows; and upper respiratory tract
infection. In adults being treated for urinary incontinence, other side effects
include UTI and painful urination. In children being treated for urinary
incontinence, other side effects include UTI; bacteria, white blood cells, and
blood in the urine. In patients being treated for urinary incontinence, another
side effect includes the inability to empty your bladder on your own. If you
have difficulty fully emptying your bladder on your own after receiving BOTOX,
you may need to use disposable self-catheters to empty your bladder up to a few
times each day until your bladder is able to start emptying again.

For more information, refer to the Medication Guide or talk with your doctor.

You are encouraged to report negative side effects of prescription drugs to the
FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see BOTOX® full Product Information, including Boxed Warning and
Medication Guide, or visit https://www.rxabbvie.com/pdf/botox_pi.pdf.

Please see BOTOX® Cosmetic full Product Information, including Boxed Warning and
Medication Guide, or visit https://www.rxabbvie.com/pdf/botox-cosmetic_pi.pdf.

If you are having difficulty paying for your medicine, AbbVie may be able to
help. Visit AbbVie.com/PatientAccessSupport to learn more.

US-BTX-240442



AbbVie may use and disclose online usage data about you collected automatically
through online tracking technologies such as cookies, pixels, and web beacons
(collectively, “cookies”). We use this data for multiple purposes, including for
online targeted advertising (advertisements based on your interests inferred
from your activity across other unaffiliated sites and services) and website
analytics purposes, as well as to personalize content, save your preferences,
provide social media features, and track the site’s performance, as further
described in the"Cookies and similar tracking and data collection technologies"
section of our Privacy Notice. We retain this data for as long as necessary to
fulfill these purposes or as needed to comply with our record retention
obligations. We do not sell your data, but we may disclose it to our marketing
and advertising partners for purposes of online targeted advertising or for
website analytics purposes. To opt out of the use or disclosure of your
cookie-based personal data for online targeted advertising or for website
analytics purposes, or to otherwise manage your preferences, please click on
Cookie Settings below. For additional information on the categories of data we
collect, the purposes for their collection, disclosures to third parties, and
data retention, please visit ourPrivacy Notice.

Cookies Settings



PRIVACY PREFERENCE CENTER

You can choose not to allow some types of cookies. Click on the different
category headings to find out more and change our default settings. However,
blocking some types of cookies may impact your experience of the site and the
services we are able to offer.

Depending on the jurisdiction where you live, you may have the right to opt out
of the use and disclosure of your personal data for purposes of online targeted
advertising (advertisements based on your interests inferred from your activity
across other unaffiliated sites and services) or website analytics (to
understand website usage behavior and receive website analytics). To opt out of
the use and disclosure of your cookie-based personal data for these purposes,
you can toggle off “Functional” (for website analytics) and/or “Advertising”
(for online targeted advertising) below.

To opt out of the use and disclosure of your non-cookie-based information for
online targeted advertising purposes, please also click"Your Privacy Choices" on
our website.

Note that if we recognize your Global Privacy Control (GPC) as enabled, our
policy is to opt you out of the use or disclosure of your cookie-based personal
data for online targeted advertising and website analytics purposes for the
browser or device on which you have GPC enabled. However, unless you are logged
in to an AbbVie account that has the capability to link the personal data we
have about you to your browser or device, we cannot apply your GPC opt-out
request to your non-cookie based personal data because the connection between
your browser or device is not known to us. Thus, if you have GPC enabled, please
click"Your Privacy Choices" to opt out of the disclosure of your non-cookie
based personal data for these purposes.


MANAGE CONSENT PREFERENCES

REQUIRED COOKIES

Always Active

These cookies are necessary for the website to function and cannot be switched
off in our systems. They may be set by us or by third party providers whose
services we have added to our pages. They are usually only set in response to
actions made by you which amount to a request for services, such as setting your
privacy preferences, logging in or filling in forms. You can set your browser to
block or alert you about these cookies, but some parts of the site will not then
work.

View Vendor Details‎

FUNCTIONAL COOKIES

Functional Cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They may be set by us or by third party
providers whose services we have added to our pages. They help us to know which
pages are the most and least popular and see how visitors move around the site.

View Vendor Details‎

ADVERTISING COOKIES

Advertising Cookies

These cookies may be set through our site by our advertising partners to build a
profile of your interests and show you relevant adverts on other sites. They do
not store directly personal information but are based on uniquely identifying
your browser and internet device. If you do not allow these cookies, you will
experience less targeted advertising, but you will still receive online
advertising.

View Vendor Details‎
Back Button


VENDORS LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Confirm My Choices